Beatrice Balboni

6PUBLICATIONS
33CO-AUTHORS
Molecular targetsBiologically active moleculesRadiation therapyCharacterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 20, 2026
Correction: Chronic administration of Metformin exerts cytostatic and cytotoxic effects via the PP2A-GSK3β-MCL-1 pathway by inhibiting the tmCLIC1 membrane protein in glioblastoma-initiating cells.

Francesca Cianci, Ivan Verduci, Riccardo Cazzoli

|Nov 23, 2025
Chronic administration of metformin exerts cytostatic and cytotoxic effects via the PP2A-GSK3β-MCL-1 pathway by inhibiting the tmCLIC1 membrane protein in glioblastoma-initiating cells.

Francesca Cianci, Ivan Verduci, Riccardo Cazzoli

|Aug 07, 2024
An integrative structural study of the human full-length RAD52 at 2.2 Å resolution.

Beatrice Balboni, Roberto Marotta, Francesco Rinaldi

|Nov 04, 2023
Isolation and Characterization of Monomeric Human RAD51: A Novel Tool for Investigating Homologous Recombination in Cancer.

Francesco Rinaldi, Fabrizio Schipani, Beatrice Balboni

|Apr 28, 2023
GSK-3β Allosteric Inhibition: A Dead End or a New Pharmacological Frontier?

Beatrice Balboni, Mirco Masi, Walter Rocchia

|Apr 12, 2022
Identification of Novel GSK-3β Hits Using Competitive Biophysical Assays.

Beatrice Balboni, Shailesh Kumar Tripathi, Marina Veronesi

Pageof 1

Frequent Collaborators

6 joint publications

Stefania Girotto

5 joint publications

Andrea Cavalli

4 joint publications

Marina Veronesi

2 joint publications

Matteo Ranucci